Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: A systematic review and meta-analysis

Cardiovascular Diabetology

Volumn 15, Issue 1, 2016, Pages

  Kar, Debasish ^a,c   Gillies, Clare ^a   Zaccardi, Francesco ^a   Webb, David ^a   Seidu, Samuel ^a   Tesfaye, Solomon ^b   Davies, Melanie ^a   Khunti, Kamlesh ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c Derbyshire Community Health Services NHS Foundation Trust   (United Kingdom)

Author keywords

Diabetes; Glycosylated haemoglobin (HbA1c); Low density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol: blood pressure (systolic and diastolic SBP and DBP); Smoking; Smoking cessation

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

CARDIOMETABOLIC PARAMETERS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID ANALYSIS; MEDICAL PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; NON SMOKER; REVIEW; SMOKING; SMOKING AND SMOKING RELATED PHENOMENA; SMOKING CESSATION; SMOKING HABIT; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; ADVERSE EFFECTS; BLOOD; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; META ANALYSIS; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PREVENTION AND CONTROL; PROGNOSIS; PROTECTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TIME FACTOR;

BIOMARKERS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; METABOLIC SYNDROME X; PROGNOSIS; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 84997531289     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-016-0475-5     Document Type: Review

References (52)

1. Machii R, Saika K. Mortality attributable to tobacco by region based on the WHO global report. Jpn J Clin Oncol. 2012;42(5):464.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Plos Med. 2006;3(11):e442.
3. Bornemisza P, Suciu I. Effect of cigarette smoking on the blood glucose level in normals and diabetics. Med Interne. 1980;18(4):353-6.
4. Weinberg JM. Lipotoxicity. Kidney Int. 2006;70(9):1560-6.
5. Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care. 1999;22(11):1887-98.
6. Al-Delaimy WK, Willett WC, Manson JE, Speizer FE, Hu FB. Smoking and mortality among women with type 2 diabetes: the Nurses' Health Study cohort. Diabetes Care. 2001;24(12):2043-8.
7. Nilsson PM, Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Fagard R, et al. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register. Eur J Cardiovasc Prev Rehabil. 2009;16:506-12.
8. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140-9.
9. Home P, Mant J, Diaz J, Turner C. Guideline Development Group. Management of type 2 diabetes: summary of updated NICE guidance. BMJ. 2008;336(7656):1306-8.
10. Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD. Vascular complications of diabetes. Br Med J. 2000;320(7241):1062.
11. Malarcher AM, Ford ES, Nelson DE, Chrismon JH, Mowery P, Merritt RK, et al. Trends in cigarette smoking and physicians' advice to quit smoking among people with diabetes in the U.S. Diabetes Care. 1995;18(5):694.
12. Emery RL, Levine MD, Cheng Y, Marcus MD. Change in body weight does not mediate the relationship between exercise and smoking cessation among weight-concerned women smokers. Nicotine Tob Res. 2015;17(9):1142.
13. Brown S. Weight gain after stopping smoking may modify the health benefits. Menopause Int. 2013;19(3):106.
14. Ussher MH, Taylor AH, Faulkner GEJ. Exercise interventions for smoking cessation. Cochrane Database Syst Rev. 2014;8:CD002295.
15. Aveyard P, Lycett D, Farley A. Managing smoking cessation-related weight gain. Polskie Archiwum Medycyny Wewnȩtrznej. 2012;122(10):494.
16. Onat A. Smoking cessation and the risk for type 2 diabetes mellitus. Ann Intern Med. 2010;152(11):754-5.
17. Stein JH, Asthana A, Smith SS, Piper ME, Loh W, Fiore MC, et al. Smoking cessation and the risk of diabetes mellitus and impaired fasting glucose: three-year outcomes after a quit attempt. PLoS ONE. 2014;9(6):e98278.
18. Ziegelstein RC. Smoking cessation and the risk for type 2 diabetes mellitus [1]. Ann Intern Med. 2010;152(11):754.
19. Filozof C, Fernández Pinilla MC, Fernández-Cruz A. Smoking cessation and weight gain. Obes Rev. 2004;5(2):95-103.
20. Clair C, Cornuz J. Diabetes: risk of diabetes mellitus: should smokers quit smoking? Nature Rev Endocrinol. 2010;6(5):250-1.
21. Campbell SC, Moffatt RJ, Stamford BA. Smoking and smoking cessation-the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 2008;201(2):225-35.
22. Berlin I. Smoking-induced metabolic disorders: a review. Diabetes Metab. 2008;34(4 Pt 1):307-14.
23. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-9.
24. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008-12.
25. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-5.
26. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring Inconsistency In Meta-Analyses. BMJ Br Med J. 2003;327(7414):557-60.
27. Ohkuma T, Iwase M, Fujii H, Kaizu S, Ide H, Jodai T, et al. Dose-and time-dependent association of smoking and its cessation with glycemic control and insulin resistance in male patients with type 2 diabetes mellitus: the fukuoka diabetes registry. PLoS ONE. 2015;10(3):e0122023.
28. Sherman JJ. The Impact of Smoking and Quitting Smoking on Patients With Diabetes. Diabetes Spectrum 2005;18(4):202-8
29. Eliasson B, Attvall S, Taskinen MR, Smith U, Sahlgrenska akademin, Institutionen för invärtesmedicin, et al. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest. 1997;27(5):450.
30. Chaturvedi N, Stevens L, Fuller JH. Which features of smoking determine mortality risk in former cigarette smokers with diabetes? The World Health Organization Multinational Study Group. Diabetes Care. 1997;20(8):1266-72.
31. Agarwal R. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. BMC Nephrol. 2005;6:13.
32. Magis D, Geronooz I, Scheen AJ. Smoking, insulin resistance and type 2 diabetes. Rev Med Liege. 2002;57(9):575-81.
33. Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation. 1994;90(1):27-34.
34. Eliasson M, Asplund K, Evrin P, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA study. Atherosclerosis. 1995;113(1):41-53.
35. Karthikeyan VJ, Bakris G, MacFadyen RJ. The ADVANCE trial: further PROGRESS with HOPE. J Hum Hypertens. 2007;21(12):911-3.
36. Oates JA, Wood AJ, Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319(20):1318-30.
37. Stubbe I, Eskilsson J, Nilsson-Ehle P, Department of Laboratory Medicine L, Section I-II, Medicin, et al. High-density lipoprotein concentrations increase after stopping smoking. Br Med J (Clinical Research Edition). 1982;284(6328):1511-3.
38. Khan HA, Sobki SH, Khan SA. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clin Exp Med. 2007;7(1):24-9.
39. Stamford BA, Matter S, Fell RD, Papanek P. Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids. Am J Clin Nutr. 1986;43(4):486-94.
40. Meigs JB, Nathan DM, Cupples LA, Wilson PW, Singer DE. Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol 1996;49(4):411-17
41. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension. 2001;37(2):187-93.
42. Reynolds K, Liese AD, Anderson AM, Dabelea D, Standiford D, Daniels SR, et al. Prevalence of tobacco use and association between cardiometabolic risk factors and cigarette smoking in youth with type 1 or type 2 diabetes mellitus. J Pediatr. 2011;158(4):594-601 e1.
43. Hofer SE, Rosenbauer J, Grulich-Henn J, Naeke A, Fröhlich-Reiterer E, Holl RW, et al. Smoking and metabolic control in adolescents with type 1 diabetes. J Pediatr. 2009;154(1):20-3 e1.
44. Thomas G, Tomlinson B, McGhee S, Lam T, Abdullah A, Yeung V, et al. Association of smoking with increasing vascular involvement in type 2 diabetic Chinese patients. Exp Clin Endocrinol Diabetes. 2006;114(06):301-5.
45. Schwab KO, Doerfer J, Hallermann K, Krebs A, Schorb E, Krebs K, et al. Marked smoking-associated increase of cardiovascular risk in childhood type 1 diabetes. Int J Adolesc Med Health. 2008;20(3):285-92.
46. Wakabayashi I. Smoking and lipid-related indices in patients with diabetes mellitus. Diabetic Med. 2014;31(7):868-78.
47. Hansen KW, Pedersen MM, Christiansen JS, Mogensen CE. Night blood pressure and cigarette smoking: disparate association in healthy subjects and diabetic patients. Blood Press. 1994;3(6):381-8.
48. Nilsson P, Gudbjörnsdottir S, Eliasson B, Cederholm J. Steering Committee of the Swedish National Diabetes Register. Smoking is associated with increased HbA 1c values and microalbuminuria in patients with diabetes-data from the National Diabetes Register in Sweden. Diabetes Metab. 2004;30(3):261-8.
49. Gerber P, Locher R, Schmid B, Spinas G, Lehmann R. Smoking is associated with impaired long-term glucose metabolism in patients with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2013;23(2):102-8.
50. Ohkuma T, Iwase M, Fujii H, Kaizu S, Ide H, Jodai T, et al. Dose-and time-dependent association of smoking and its cessation with glycemic control and insulin resistance in male patients with type 2 diabetes mellitus: the fukuoka diabetes registry. PLoS ONE. 2015;10(3):e0122023.
51. Lycett D, Nichols L, Ryan R, Farley A, Roalfe A, Mohammed MA, et al. The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study. Lancet Diabetes Endocrinol. 2015;3(6):423-30.
52. Iino K, Iwase M, Tsutsu N, Iida M. Smoking cessation and glycaemic control in type 2 diabetic patients. Diabetes Obes Metab. 2004;6(3):181-6.